Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


18.12.2017

21 Am J Respir Crit Care Med
7 Ann Allergy Asthma Immunol
1 Arch Bronconeumol
1 BMJ
9 Chest
2 Eur Respir J
2 J Allergy Clin Immunol
3 J Asthma
1 Pediatrics
5 PLoS One
7 Respir Med
1 Respir Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. KEET CA, Keller JP, Peng RD
    Long-term Coarse PM Exposure is Associated with Asthma Among Children in Medicaid.
    Am J Respir Crit Care Med. 2017 Dec 15. doi: 10.1164/rccm.201706-1267.
    PubMed     Text format     Abstract available

  2. CHANDRA D, Palevsky P, Sciurba FC
    EnRAGEed Kidneys in Chronic Obstructive Pulmonary Disease?
    Am J Respir Crit Care Med. 2017;195:1411-1413.
    PubMed     Text format    

  3. LIPSON DA, Barnacle H, Birk R, Brealey N, et al
    Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".
    Am J Respir Crit Care Med. 2017;196:1083-1084.
    PubMed     Text format    

  4. SINGH D, Vestbo J
    Triple Therapy in Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;196:1082-1083.
    PubMed     Text format    

  5. LIPWORTH BJ, Jabbal S
    FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;196:1082.
    PubMed     Text format    

  6. NATH A, Khan A, Hashim Z
    Is Concomitant Use of Theophylline and Roflumilast Really Contraindicated?
    Am J Respir Crit Care Med. 2017;195:1406-1407.
    PubMed     Text format    

  7. AU DH, Feemster LC
    It's Bad-Really Bad-But Does it Matter? Medication Adherence in Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;195:1282-1283.
    PubMed     Text format    

  8. CALVERLEY PMA
    A Light in the Darkness? The FLAME Trial, Blood Eosinophils, and Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;195:1125-1127.
    PubMed     Text format    

  9. SATHIYAMOORTHY G, Lau C, Marlow S, Hatipoglu U, et al
    Controlled Clinical Trials and Real-Life Experience with Pulmonary Rehabilitation.
    Am J Respir Crit Care Med. 2017;196:796-797.
    PubMed     Text format    

  10. GUELL MR, Celli B
    Reply: Controlled Clinical Trials and Real-Life Experience with Pulmonary Rehabilitation.
    Am J Respir Crit Care Med. 2017;196:797.
    PubMed     Text format    

  11. VESTBO J, Lange P
    Exposure Interaction: A Lifelong Phenomenon with Relevance to Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;196:947-948.
    PubMed     Text format    

  12. SOHAL SS, Eapen MS, Ward C, Walters EH, et al
    Epithelial-Mesenchymal Transition: A Necessary New Therapeutic Target in Chronic Obstructive Pulmonary Disease?
    Am J Respir Crit Care Med. 2017;196:393-394.
    PubMed     Text format    

  13. SINGH D
    Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease. Blood Eosinophils Gain Momentum.
    Am J Respir Crit Care Med. 2017;196:1098-1100.
    PubMed     Text format    

  14. CAPALDI DPI, Parraga G
    Through the Looking Glass and What Was Found There: Imaging Biomarkers of Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;196:1364-1366.
    PubMed     Text format    

  15. TASHKIN DP, Taube C
    Triple Therapy for Chronic Obstructive Pulmonary Disease Management. Are Our Expectations Fulfilled?
    Am J Respir Crit Care Med. 2017;196:402-404.
    PubMed     Text format    

  16. ARCE SC, De Vito EL
    More Breathing, Less Fitness: Lessons from Exercise Physiology in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap.
    Am J Respir Crit Care Med. 2017;196:1233-1234.
    PubMed     Text format    

  17. QUADERI S, Hurst JR
    One-off Spirometry Is Insufficient to Rule In or Rule Out Mild to Moderate Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;196:254-256.
    PubMed     Text format    

  18. BODDULURI S, Reinhardt JM, Hoffman EA, Newell JD Jr, et al
    Signs of Gas Trapping in Normal Lung Density Regions in Smokers.
    Am J Respir Crit Care Med. 2017;196:1404-1410.
    PubMed     Text format     Abstract available

  19. ROCHE N, Chapman KR, Vogelmeier CF, Herth FJF, et al
    Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
    Am J Respir Crit Care Med. 2017;196:1230-1231.
    PubMed     Text format    

  20. YILMAZ I, Turk M
    What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
    Am J Respir Crit Care Med. 2017;196:1229-1230.
    PubMed     Text format    

  21. YANG J, Shaykhiev R
    Reply: Epithelial-Mesenchymal Transition: A Necessary New Therapeutic Target in Chronic Obstructive Pulmonary Disease?
    Am J Respir Crit Care Med. 2017;196:394-395.
    PubMed     Text format    


    Ann Allergy Asthma Immunol

  22. MARC MALOVRH M, Rozman A, Skrgat S, Silar M, et al
    Bronchial thermoplasty induces immunomodulation with a significant increase in pulmonary CD4(+)25(+) regulatory T cells.
    Ann Allergy Asthma Immunol. 2017;119:289-290.
    PubMed     Text format    

  23. BARTON JC, Barton JC, Bertoli LF
    Hypogammaglobulinemia E in 216 adults with IgG subclass deficiency and respiratory tract infections.
    Ann Allergy Asthma Immunol. 2017;119:292-294.
    PubMed     Text format    

  24. ENDO Y, Shirai T, Akamatsu T, Asada K, et al
    Comparison of fractional exhaled nitric oxide levels measured using the NIOX VERO and NOA 280i.
    Ann Allergy Asthma Immunol. 2017;119:383-385.
    PubMed     Text format    

  25. OPPENHEIMER JJ, Greenberger PA
    Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.
    Ann Allergy Asthma Immunol. 2017;119:474-475.
    PubMed     Text format    

  26. OPPENHEIMER JJ, Marshall GD Jr
    Increasing our knowledge base of asthma.
    Ann Allergy Asthma Immunol. 2017;119:476-479.
    PubMed     Text format    

  27. OGUNDIPE F, Hennis ECA, Mehari A, Gillum RF, et al
    Toxocara species exposure, symptoms of asthma, and fractional exhaled nitric oxide in the US population.
    Ann Allergy Asthma Immunol. 2017;119:569-570.
    PubMed     Text format    

  28. WOOLNOUGH K, Craner M, Pashley CH, Wardlaw AJ, et al
    rAsp f 3 and rAsp f 4 are associated with bronchiectasis in allergic fungal airways disease.
    Ann Allergy Asthma Immunol. 2017 Dec 7. pii: S1081-1206(17)31193.
    PubMed     Text format    


    Arch Bronconeumol

  29. PEREZ DE LLANO L, Cosio BG, Miravitlles M, Plaza V, et al
    Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
    Arch Bronconeumol. 2017 Dec 8. pii: S0300-2896(17)30396.
    PubMed     Text format     Abstract available


    BMJ

  30. ANDREW E, Nehme Z, Bernard S, Abramson MJ, et al
    Stormy weather: a retrospective analysis of demand for emergency medical services during epidemic thunderstorm asthma.
    BMJ. 2017;359:j5636.
    PubMed     Text format     Abstract available


    Chest

  31. MCNICHOLAS WT
    COPD-OSA Overlap Syndrome: Evolving Evidence Regarding Epidemiology, Clinical Consequences, and Management.
    Chest. 2017;152:1318-1326.
    PubMed     Text format     Abstract available

  32. MOORE E, Newson R, Joshi M, Palmer T, et al
    Effects of Pulmonary Rehabilitation on Exacerbation Number and Severity in People With COPD: An Historical Cohort Study Using Electronic Health Records.
    Chest. 2017;152:1188-1202.
    PubMed     Text format     Abstract available

  33. MARTINEZ FJ, Fabbri LM, Ferguson GT, Orevillo C, et al
    Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD.
    Chest. 2017;152:1169-1178.
    PubMed     Text format     Abstract available

  34. CLAY RD, Iyer VN, Reddy DR, Siontis B, et al
    The "Complex Restrictive" Pulmonary Function Pattern: Clinical and Radiologic Analysis of a Common but Previously Undescribed Restrictive Pattern.
    Chest. 2017;152:1258-1265.
    PubMed     Text format     Abstract available

  35. ZHANG W, Zhang Y, Li CW, Jones P, et al
    Effect of Statins on COPD: A Meta-Analysis of Randomized Controlled Trials.
    Chest. 2017;152:1159-1168.
    PubMed     Text format     Abstract available

  36. HUSTA BC, Raoof S, Erzurum S, Mehta AC, et al
    Tracheobronchopathy From Inhaled Corticosteroids.
    Chest. 2017;152:1296-1305.
    PubMed     Text format     Abstract available

  37. DAVIS BE, Simonson SK, Blais CM, Cockcroft DW, et al
    Methacholine Challenge Testing: A Novel Method for Measuring PD20.
    Chest. 2017;152:1251-1257.
    PubMed     Text format     Abstract available

  38. STRASSMANN A, Frei A, Haile SR, Ter Riet G, et al
    Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4(1/2) Year Prospective Cohort Study.
    Chest. 2017;152:1179-1187.
    PubMed     Text format     Abstract available

  39. CHALMERS JD, Restrepo MI
    Bronchiectasis Management: The State of the Union.
    Chest. 2017;152:1097-1099.
    PubMed     Text format    


    Eur Respir J

  40. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    PubMed     Text format    

  41. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    J Allergy Clin Immunol

  42. OLIVERIA JP, El-Gammal AI, Yee M, Obminski CD, et al
    Changes in regulatory B cell levels in bone marrow, blood and sputum of asthmatics following inhaled allergen challenge.
    J Allergy Clin Immunol. 2017 Dec 6. pii: S0091-6749(17)31879.
    PubMed     Text format     Abstract available

  43. YANCEY SW, Keene ON, Albers FC, Ortega H, et al
    Biomarkers for severe eosinophilic asthma.
    J Allergy Clin Immunol. 2017;140:1509-1518.
    PubMed     Text format     Abstract available


    J Asthma

  44. HONG J, Bao Y, Chen A, Li C, et al
    Chinese guidelines for childhood asthma 2016: Major updates, recommendations and key regional data.
    J Asthma. 2017 Dec 11:1-9. doi: 10.1080/02770903.2017.1396474.
    PubMed     Text format     Abstract available

  45. ARIKOGLU T, Unlu A, Yildirim DD, Kuyucu S, et al
    The airway hyperresponsiveness to methacholine may be predicted by impulse oscillometry and plethysmography in children with well-controlled asthma.
    J Asthma. 2017 Dec 12:1-8. doi: 10.1080/02770903.2017.1407337.
    PubMed     Text format     Abstract available

  46. BIALEK-GOSK K, Maskey-Warzechowska M, Krenke R, Dabrowska M, et al
    Menopausal asthma-much ado about nothing? An observational study.
    J Asthma. 2017 Dec 14:1-8. doi: 10.1080/02770903.2017.1407336.
    PubMed     Text format     Abstract available


    Pediatrics

  47. SCHUH S, Babl FE, Dalziel SR, Freedman SB, et al
    Practice Variation in Acute Bronchiolitis: A Pediatric Emergency Research Networks Study.
    Pediatrics. 2017;140.
    PubMed     Text format     Abstract available


    PLoS One

  48. SWAMINATHAN S, Qirko K, Smith T, Corcoran E, et al
    A machine learning approach to triaging patients with chronic obstructive pulmonary disease.
    PLoS One. 2017;12:e0188532.
    PubMed     Text format     Abstract available

  49. ANDRES-BLANCO AM, Alvarez D, Crespo A, Arroyo CA, et al
    Assessment of automated analysis of portable oximetry as a screening test for moderate-to-severe sleep apnea in patients with chronic obstructive pulmonary disease.
    PLoS One. 2017;12:e0188094.
    PubMed     Text format     Abstract available

  50. GALLARDO-ESTRELLA L, Pompe E, de Jong PA, Jacobs C, et al
    Normalized emphysema scores on low dose CT: Validation as an imaging biomarker for mortality.
    PLoS One. 2017;12:e0188902.
    PubMed     Text format     Abstract available

  51. YEH JJ, Lin CL, Hsu WH, Kao CH, et al
    The relationship of depression in asthma-chronic obstructive pulmonary disease overlap syndrome.
    PLoS One. 2017;12:e0188017.
    PubMed     Text format     Abstract available

  52. MONTES DE OCA M, Menezes A, Wehrmeister FC, Lopez Varela MV, et al
    Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.
    PLoS One. 2017;12:e0186777.
    PubMed     Text format     Abstract available


    Respir Med

  53. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Text format     Abstract available

  54. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Text format     Abstract available

  55. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Text format     Abstract available

  56. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Text format     Abstract available

  57. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Text format     Abstract available

  58. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Text format     Abstract available

  59. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    PubMed     Text format    


    Respir Res

  60. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: